Cyclosporine-Loaded Nano-Structured Lipid Carriers for Sustained Ophthalmic Delivery

• Optimized lipid carrier formulation improving cyclosporine bioavailability by 38% while maintaining ophthalmic safety parameters.

• Conducted stability and in-vitro release studies, improving formulation uniformity by 42% using analytical characterization techniques.

• Performed particle size and zeta potential optimization, reducing PDI variation by 27% to ensure long-term formulation stability.